ProxyMed, Inc. (Nasdaq:PILL), a leading provider of healthcare transaction processing and medical cost containment services, today announced receipt of a notice from the Nasdaq Listing Qualifications staff indicating that because the Company had failed to timely file its form 10-Q for the period ended September 30, 2004, it is not in compliance with the filing requirements for continued listing required by Nasdaq Marketplace Rule 4310(c)(14). As of the opening of business November 18, 2004, an “E” was appended to the end of the Company’s ticker symbol “PILL” for the Company’s common stock. As a result of this Nasdaq notification, the Company’s securities are potentially subject to delisting from the Nasdaq National Market commencing with the opening of business on November 26, 2004, unless an appeal is made to a Nasdaq Listings Qualifications Panel (“Panel”) within seven calendar days of the Company’s receipt of such notice. The Company intends to appeal the delisting notification and request a hearing by a Panel. The filing of a hearing request will stay the delisting process pending the Panel’s decision.
